scholarly journals Temporary faecal diversion in ileocolic resection for Crohn’s disease: is there an impact on long‐term surgical recurrence?

2019 ◽  
Vol 22 (4) ◽  
pp. 430-438
Author(s):  
R. Bolckmans ◽  
S. Singh ◽  
K. Ratnatunga ◽  
D. Wickramasinghe ◽  
K. Sahnan ◽  
...  
2020 ◽  
Author(s):  
Hiroki Ikeuchi ◽  
Motoi Uchino ◽  
Toshihiro Bando ◽  
Yuki Horio ◽  
Ryuichi Kuwahara ◽  
...  

Abstract Background Crohn’s disease (CD) recurrence can occur not only at the site of anastomosis but also elsewhere in the bowel following ileocolic resection (ICR). The aims of the present study were to assess long-term outcomes of a primary ICR procedure for CD in consecutive patients and examine the location of the reoperation causative lesion. Methods We examined cases of surgery with ICR initially performed at our institution. Those with a simultaneous multiple bowel resection or bowel resection with strictureplasty were excluded. Results A total of 169 patients who underwent ICR due to CD were enrolled. The median follow-up period was 12.6 years (range 4–27 years). A reoperation was needed in 45 (26.6%), of whom 14 had lesions causative of the reoperation at other than the anastomotic site. The most common causative lesion location was in the colon rather than the oral side of the small intestine. Furthermore, we investigated the relationship between presence of residual lesions following the initial surgery and lesions causative of reoperation. In the group without residual disease (n = 31), 29.0% (n = 9) had non-anastomotic lesions involved in indications for reoperation, while that was 35.7% (n = 5) in the group with residual disease (n = 14). Conclusions Anastomotic site lesion is not the only causative factor for reoperation following ICR. Regular examinations and applicable treatment with awareness that the cause of reoperation is not limited to the site of anastomosis are important in these cases.


2010 ◽  
Vol 97 (4) ◽  
pp. 563-568 ◽  
Author(s):  
E. J. Eshuis ◽  
J. F. M. Slors ◽  
P. C. F. Stokkers ◽  
M. A. G. Sprangers ◽  
D. T. Ubbink ◽  
...  

2020 ◽  
Vol 63 (2) ◽  
pp. 200-206
Author(s):  
Roel Bolckmans ◽  
Thordis Kalman ◽  
Sandeep Singh ◽  
Keshara C. Ratnatunga ◽  
Pär Myrelid ◽  
...  

2019 ◽  
Vol 22 (2) ◽  
pp. 170-177 ◽  
Author(s):  
L. W. Unger ◽  
S. Argeny ◽  
A. Stift ◽  
Y. Yang ◽  
A. Karall ◽  
...  

2012 ◽  
Vol 142 (5) ◽  
pp. S-1072
Author(s):  
Felipe Bellolio ◽  
Zane Cohen ◽  
Helen M. MacRae ◽  
J.Charles Victor ◽  
Brenda I. O'Connor ◽  
...  

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S431-S432
Author(s):  
A Frontali ◽  
A Chierici ◽  
X Treton ◽  
L Maggiori ◽  
Y Bouhnik ◽  
...  

Abstract Background According to recent literature, extended colectomy (EC) and segmental colectomy (SC) are equally effective for colonic Crohn’s disease (CCD), with no differences in terms of postoperative morbidity, incidence of long-term recurrence and definitive stoma, but earlier recurrence is observed in patients with SC. Our objective was to evaluate our comparative results between EC and SC. Methods All consecutive patients undergoing surgery for CCD (EC vs. SC) in our Centre were included and compared and we evaluated postoperative morbidity, long-term clinical and surgical recurrence. Results One hundred and twelve patients (mean age at diagnosis of CD, 31 ± 17 years, mean age at surgery 42 ± 17 years) with CCD underwent EC (n = 45) or SC (n = 67); 62 (55%) patients presenting concomitant small bowel disease, 10 (9%) an extra-intestinal manifestation and 16 (14%) were active smokers. Postoperative morbidity was 8/45 (18%) in case of EC vs. 9/67 (13%) in case of SC (NS). In EC group, 8/8 (100%) complicated patients vs. 16/37 (43%) uncomplicated patients were under anti-TNF before surgery (p = 0.04). This significant difference was not showed in SC group. After a median follow-up of 40 ± 34 months (range 1–130), clinical recurrence incidence was 15/45 (33%) in EC vs. 27/67 (40%) in SC patients (NS) and surgical recurrence was 8/45 (18%) in CE vs. 13/67 (19%) in CS patients (NS). Recurrence of the disease occurred after 19 ± 20 months (range, 1–74) in EC vs. 14 ± 26 months (range, 1–130) in CS patients (p = NS). Conclusion Our study confirms that in case of surgery for CCD, EC and SC are equally safe and feasible but recurrence happens earlier after SC than EC. Additionally, the role of anti-TNF is confirmed for postoperative complications.


Sign in / Sign up

Export Citation Format

Share Document